Single Targeted Exon Mutation Creates a True Congenic Mouse for Competitive Hematopoietic Stem Cell Transplantation: The C57BL/6-CD45.1STEM Mouse Scientists demonstrated that a single amino acid change determines the CD45.1 epitope. Further, they report on the single targeted exon mutant (STEM) mouse strain, CD45.1STEM, which is functionally equivalent to CD45.2 cells in competitive bone marrow transplants. [Stem Cell Reports] Full Article | Graphical Abstract High Levels of Canonical Wnt Signaling Lead to Loss of Stemness and Increased Differentiation in Hematopoietic Stem Cells In the blood system, the role of Wnt signaling has been the subject of much debate but there is consensus that high Wnt signals lead to loss of reconstituting capacity. To better understand this phenomenon, the authors have taken advantage of a series of hypomorphic mutant Apc alleles resulting in a broad range of Wnt dosages in hematopoietic stem cells and performed whole-genome gene expression analyses. [Stem Cell Reports] Full Article Expression of CDKN1C in the Bone Marrow of Patients with Myelodysplastic Syndrome and Secondary Acute Myeloid Leukemia Is Associated with Poor Survival after Conventional Chemotherapy Investigators tested the hypothesis that proliferative activity of hematopoietic stem cells has impact on survival in newly diagnosed patients with myelodysplastic syndrome and secondary acute myeloid leukemia. [Int J Cancer] Abstract Calreticulin-Mutant Proteins Induce Megakaryocytic Signaling to Transform Hematopoietic Cells and Undergo Accelerated Degradation and Golgi-Mediated Secretion Researchers demonstrated the potency of calreticulin mutants to drive expression of megakaryocytic differentiation markers such as NF-E2 and CD41 as well as thrombopoietin receptor. [J Hematol Oncol] Full Article Repression of Primitive Erythroid Program Is Critical for the Initiation of Multi-Lineage Hematopoiesis in Mouse Development Investigators found that the earliest committed hematopoietic progenitors highly expressed Gata1, Scl/tal1, and Klf1 genes. Expression of these transcription factors, which is known to form a core erythroid transcriptional network, explained the prompt generation of primitive erythrocytes from these earliest progenitors. [J Cell Physiol] Abstract MLL1 and MLL1 Fusion Proteins Have Distinct Functions in Regulating Leukemic Transcription Program The authors demonstrated that mixed lineage leukemia protein-1 (MML1), probably through C-terminal interaction with WDR5, is recruited to regulatory enhancers that are enriched for binding sites of E-twenty-six family transcription factors, whereas MLL-AF9 binds to chromatin regions that have no H3K4me1 enrichment. [Cell Disc] Abstract CLINICAL RESEARCH Phase II Study of Intensified Chemotherapy and Allogeneic Hematopoietic Stem Cell Transplantation for Older Patients with Acute Lymphoblastic Leukemia Scientists determined the efficacy of an intensified, multi-agent approach derived from a Dana-Farber consortium trial in younger adults for patients older than 50 years. [Cancer] Abstract Busulfan, Melphalan, and Bortezomib versus High Dose Melphalan as a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma The authors compared a novel conditioning combination incorporating busulfan, melphalan and bortezomib versus standard melphalan 200 mg/m2 in newly diagnosed patients undergoing autologous hematopoietic cell transplantation for multiple myeloma. [Biol Blood Marrow Transplant] Abstract Filgrastim-Stimulated Bone Marrow Compared to Filgrastim-Mobilized Peripheral Blood in Myeloablative Sibling Allografting for Patients with Hematologic Malignancies: A Randomized Canadian Blood and Marrow Transplant Group Study Researchers conducted a Phase III, open label, multicenter randomized trial of 230 adults with hematologic malignancies receiving allografts from siblings after myeloablative conditioning to compare filgrastim-mobilized peripheral blood and filgrastim-stimulated marrow. [Biol Blood Marrow Transplant] Abstract |